Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-09T06:45:48.093Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevention and treatment of venous thromboembolism in the elderly

Published online by Cambridge University Press:  17 November 2008

HGM Shetty  and
PA Routledge
HGM Shetty*
Affiliation:
University of Wales College of Medicine, Cardiff, UK
PA Routledge
Affiliation:
University of Wales College of Medicine, Cardiff, UK
*
HGM Shetty, B6 Stem, University Hospital of Wales, Heath Park, Cardiff, South Glamorgan CF4 4XN, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 6 , Issue 4 , November 1996 , pp. 325 - 332
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Kniffin, WD Jr, Baron, JA, Barrett, J et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861–66.CrossRefGoogle ScholarPubMed
2Mangion, DM. Pulmonary embolism – incidence and prognosis in hospitalised elderly. Postgrad Med J 1989; 65: 814–17.CrossRefGoogle Scholar
3Sandler, DA, Martin, JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203–205.CrossRefGoogle ScholarPubMed
4Fratantoni, J, Wessier, S. Prophylactic therapy of deep vein thrombosis and pulmonary embolism. DHEW publ. no. (NIH) 76–866. Washington, DC: US Government Printing Office, 1975.Google Scholar
5Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992; 305: 567–74.CrossRefGoogle Scholar
6Hull, RD, Kakkar, VV, Raskob, GE. Prevention of venous thrombosis and pulmonary embolism. In: Fuster, V, Verstraete, M eds. Thrombosis in cardiovascular disorders. Philadelphia: WB Saunders Company, 1992: 451–64.Google Scholar
7Clagett, GP, Reisch, JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 1988; 208: 227–40.CrossRefGoogle ScholarPubMed
8Collins, R, Scrimgeour, A, Yusef, S, Peto, R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162–73.CrossRefGoogle ScholarPubMed
9International Multicentre Trial. Prevention of fatal post-operative pulmonary embolism by low doses of heparin. Lancet 1975; ii: 45–51.Google Scholar
10Leyvraz, PF, Richard, J, Bachmann, F et al. Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 1983; 309: 954–58.CrossRefGoogle ScholarPubMed
11Hirsh, J, Levine, MN. Low molecular weight heparin. Blood 1992; 79: 1–17.CrossRefGoogle ScholarPubMed
12Kakkar, W, Cohen, AT, Edmonson, RA et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 259–65.CrossRefGoogle ScholarPubMed
13Green, D, Hirsh, J, Keit, J et al. Low molecular weight heparin: a critical analysis of clinical trials. Pharmacol Rev 1994; 46: 89–109.Google ScholarPubMed
14Warlow, C, Ogston, D, Douglas, A. Venous thrombosis following stroke. Lancet 1972; i: 1305–306.CrossRefGoogle Scholar
15Turpie, AGG, Gent, M, Côte, R et al. A low molecular weight heparinoid compared with infractionated heparin in the prevention of deep vein thrombosis in patients with acute stroke. A randomized, double-blind study. Ann Intern Med 1992; 117: 353–57.CrossRefGoogle Scholar
16Eriksson, BI, Edman, S, Kälebo, P et al. Prevention of deep vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996; 347: 635–39.CrossRefGoogle ScholarPubMed
17Pini, M, Pattacinic, , Quintavalla, R et al. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis – a randomized clinical trial. Thromb Haemost 1990; 64: 222–26.Google ScholarPubMed
18Fennerty, A, Campbell, IA, Routledge, PA. Anticoagulants in venous thromboembolism. BMJ 1988; 297: 1285–88.CrossRefGoogle ScholarPubMed
19Lensing, AWA, Prins, MJ, Davidson, BL, Hirsh, J. Treatment of deep venous thrombosis with low molecular weight heparins. A meta-anlaysis. Arch Intern Med 1995; 155: 601–607.CrossRefGoogle Scholar
20Hull, RD, Raskob, GE, Rosenblomm, D et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990; 322 1260–64.CrossRefGoogle ScholarPubMed
21Shetty, HGM, Routledge, PA. Computer assisted anticoagulation. In: Fuster, V, Verstraete, M eds. Thrombosis in cardiovascular disorders. Philadelphia: WB Saunders, 1992: 523–27.Google Scholar
22British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force. Guidelines on oral anticoagulation: second edition, J Clin Pathol 1990; 43: 177–83.CrossRefGoogle Scholar
23Shetty, HGM, Backhouse, G, Bentley, DP et al. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1. Thromb Haemost 1992; 67: 13–15.Google ScholarPubMed
24Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep vein thrombosis and pulmonary embolism. Lancet 1992; 340: 873–76.CrossRefGoogle Scholar
25Schulman, S, Rhedin, A, Lindmarker, P et al. A comparison of six weeks with six months of oral anticoagulant therapy after first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661–65.CrossRefGoogle ScholarPubMed
26Verstraete, M, Verhaeghe, R, Routledge, PA. Anticoagulants in the elderly. In: Butchart, EG, Bodnar, E eds. Thrombosis, embolism and bleeding. London: ICR Publishers, 1992: 356–61.Google Scholar
27Routledge, PA, Chapman, PH, Davies, DM, Rawlins, MD. Factors affecting warfarin requirements – a prospective population study. Ear J Clin Pharmacol 1979; 15: 319–22.CrossRefGoogle ScholarPubMed
28Terrin, M, Goldhaber, SZ, Thompson B and the TIPE investigators. Selection of patients with acute pulmonary embolism for thrombolytic therapy. Thrombolysis in pulmonary embolism (TIPE) patient survey. Chest 1989; 95: 2795–815.Google ScholarPubMed
29Rogers, LQ, Lutcher, CL. Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med 1990; 88: 389–95.CrossRefGoogle ScholarPubMed
30Stein, PD, Hull, RD, Raskob, G. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of non-invasive management. Ann Intern Med 1994; 121: 313–17.CrossRefGoogle Scholar
31Clarke, DB, Abrams, LD. Pulmonary embolectomy: a 25-year experience. J Thorac Cardiovasc Surg 1986; 92: 442–45.CrossRefGoogle ScholarPubMed
32Meyer, G, Tamisier, D, Sors, H et al. Pulmonary embolectomy: a 20-year experience in one center. Ann Thorac Surg 1991; 51: 232–36.CrossRefGoogle ScholarPubMed
33Moser, KJ, Auger, WR, Fedullo, PF. Chronic major-vessel thrombo-embolic pulmonary hypertension. Circulation 1990; 81: 1735–43.CrossRefGoogle Scholar
34Levine, M, Gent, M, Hirsh, J et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in hospital for proximal deep vein thrombosis. N Engl J Med 1996; 334: 677–81.CrossRefGoogle ScholarPubMed